These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15590388)

  • 21. Alemtuzumab in Sézary syndrome: efficient but not innocent.
    Ure UB; Ar MC; Salihoglu A; Guner SI; Baran A; Oguz O; Ferhanoglu B
    Eur J Dermatol; 2007; 17(6):525-9. PubMed ID: 17951134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.
    Martin SI; Marty FM; Fiumara K; Treon SP; Gribben JG; Baden LR
    Clin Infect Dis; 2006 Jul; 43(1):16-24. PubMed ID: 16758413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.
    Faderl S; Thomas DA; O'Brien S; Garcia-Manero G; Kantarjian HM; Giles FJ; Koller C; Ferrajoli A; Verstovsek S; Pro B; Andreeff M; Beran M; Cortes J; Wierda W; Tran N; Keating MJ
    Blood; 2003 May; 101(9):3413-5. PubMed ID: 12522009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.
    Goussetis E; Efstathiou E; Paisiou A; Avgerinou G; Zisaki K; Giamouris VJ; Peristeri I; Kitra V; Vessalas G; Gamaletsou MN; Sipsas NV; Graphakos S
    Transpl Infect Dis; 2015 Apr; 17(2):201-7. PubMed ID: 25645592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation.
    Weissenbacher A; Boesmueller C; Brandacher G; Oellinger R; Pratschke J; Schneeberger S
    Immunotherapy; 2010 Nov; 2(6):783-90. PubMed ID: 21091110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes zoster infection after liver transplantation in patients receiving induction therapy with alemtuzumab.
    Alcaide ML; Abbo L; Pano JR; Gaynor JJ; Tryphonopoulos P; Weppler D; Moon JI; Tzakis AG; Morris MI
    Clin Transplant; 2008; 22(4):502-7. PubMed ID: 18627401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of alemtuzumab in organ transplantation: current clinical status.
    Ciancio G; Burke GW; Warque ME; Miller J
    BioDrugs; 2006; 20(2):85-92. PubMed ID: 16626166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath.
    Bainton RD; Byrne JL; Davy BJ; Russell NH
    Blood; 2002 Nov; 100(10):3843-4. PubMed ID: 12411329
    [No Abstract]   [Full Text] [Related]  

  • 30. Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature.
    Abbi KK; Rizvi SM; Sivik J; Thyagarajan S; Loughran T; Drabick JJ
    Leuk Res; 2010 Jul; 34(7):e154-6. PubMed ID: 20362332
    [No Abstract]   [Full Text] [Related]  

  • 31. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
    Peleg AY; Husain S; Kwak EJ; Silveira FP; Ndirangu M; Tran J; Shutt KA; Shapiro R; Thai N; Abu-Elmagd K; McCurry KR; Marcos A; Paterson DL
    Clin Infect Dis; 2007 Jan; 44(2):204-12. PubMed ID: 17173218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999.
    Bunjes D
    Transfus Sci; 2000 Oct; 23(2):151-62. PubMed ID: 11035276
    [No Abstract]   [Full Text] [Related]  

  • 33. Activity of alemtuzumab in patients with CD52-positive acute leukemia.
    Tibes R; Keating MJ; Ferrajoli A; Wierda W; Ravandi F; Garcia-Manero G; O'Brien S; Cortes J; Verstovsek S; Browning ML; Faderl S
    Cancer; 2006 Jun; 106(12):2645-51. PubMed ID: 16688777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab-associated infections.
    Gea-Banacloche JC
    Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
    Gómez-Almaguer D; Ruiz-Argüelles GJ; del Carmen Tarín-Arzaga L; González-Llano O; Gutiérrez-Aguirre H; Cantú-Rodríguez O; Jaime-Pérez J; Carrasco-Yalán A; Giralt S
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):10-5. PubMed ID: 18158956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?
    Smolej L
    Blood; 2008 Sep; 112(5):2167. PubMed ID: 18725576
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic monoclonal antibodies in onco-hematology].
    Cartron G; Rossi JF
    Med Sci (Paris); 2009 Dec; 25(12):1085-9. PubMed ID: 20035683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
    Saadeh CE; Srkalovic G
    Pharmacotherapy; 2008 Feb; 28(2):281-4. PubMed ID: 18225973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus retinitis.
    Rothova A; de Weerdt O
    Ophthalmology; 2009 Apr; 116(4):817-8; author reply 818-9. PubMed ID: 19344836
    [No Abstract]   [Full Text] [Related]  

  • 40. Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin.
    Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Kim SH; Kim HJ; Cho SG; Eom KS; Lee JW; Min WS; Shin WS; Kim CC
    Transpl Infect Dis; 2009 Oct; 11(5):413-23. PubMed ID: 19708893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.